Joel Greenblatt acquired 28.4 Thousand Abbvie shares worth $5.27 Million. That's 0.05% of their equity portfolio (471st largest holding). The first Abbvie trade was made in Q1 2013. Since then Joel Greenblatt bought shares 22 more times and sold shares on 25 occasions. The stake costed the investor $1.94 Million, netting the investor a gain of 171% so far.